Serving the people wholeheartedly Stock Code: Yixintang Pharmaceutical Group Co.Ltd(002727) stock abbreviation: Yixintang Pharmaceutical Group Co.Ltd(002727) Announcement No.: 2022015 Yixintang Pharmaceutical Group Co.Ltd(002727)
Announcement on the progress of the company’s purchase of land use rights from related parties
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without falsity
Records, misleading statements or material omissions.
1、 Transaction overview
Yixintang Pharmaceutical Group Co.Ltd(002727) (hereinafter referred to as “the company”) held the 9th meeting of the 5th board of directors on May 21, 2021, deliberated and approved the proposal on the company’s purchase of land use right from related parties. The company plans to purchase 2752186 ㎡ land use right from the related party Chengdu Jinhua Pharmaceutical Co., Ltd. (hereinafter referred to as “Chengdu Jinhua”) located at No. 281, section 4, xihanggang Avenue, Shuangliu district. The transfer price of this transaction is subject to the actual evaluation amount of a qualified evaluation institution recognized by both parties, and the total transaction price is expected to be no more than 9 million yuan. For details, please refer to the company’s website on May 22, 2021 (www.cn. Info. Com. CN.) Relevant announcement of disclosure (Announcement No.: 2021069). 2、 Counterparty information
1. Name: Chengdu Jinhua Pharmaceutical Co., Ltd
2. Unified social credit Code: 91510122202381139y
3. Nature of enterprise: limited liability company (sole proprietorship of legal person invested or controlled by non natural person)
4. Registered address: No. 281, section 4, xihanggang Avenue, Shuangliu District, Chengdu
5. Legal representative: Guo min
6. Registered capital: 2079918 million yuan
7. Business scope: production and sales of drugs, medical devices, labor protection articles and daily masks (non-medical); Food business; Sales: health products, sanitary products, masks, medical devices; estate management; Car Rental; hotel management; Enterprise management consulting; Conference services; Pharmaceutical technology research and development and technology transfer; Business information consulting services; Engaged in foreign trade of goods and technology import and export. (for projects that must be approved according to law, business activities can be carried out only with the approval of relevant departments). 3、 Transaction progress
The company hired Beijing Yachao Assets Appraisal Co., Ltd. to evaluate the transaction and issued Beijing Yachao appraisal report
Serve the people wholeheartedly
[2021] No. A193 appraisal report, the appraisal price is 8.9446 million yuan, and the actual transaction price is 8.9446 million yuan, which does not exceed the resolution amount. Yixintang Pharmaceutical Group Co.Ltd(002727) Pharmaceutical (Sichuan) Co., Ltd., a wholly-owned subsidiary of the company, has obtained the real property right certificate, and the relevant objects are as follows:
1. Location: No. 281, section 4, xihanggang Avenue, xihanggang street, Shuangliu District
2. Type of construction land use right: state-owned land use right
3. Purpose: industrial land
4. Area: the parcel covers an area of 2752186 square meters
5. Service life: from June 27, 2019 to June 26, 2039
4、 Impact on the company
The company’s purchase of Chengdu Jinhua land use right is necessary for the company’s business development and is conducive to promoting the operation and development of Sichuan region. This transaction has no significant impact on the current and future financial situation of the company, and there is no situation that damages the interests of the company and its shareholders, especially the minority shareholders.
5、 Documents for future reference
1. Real estate title certificate.
It is hereby announced.
Yixintang Pharmaceutical Group Co.Ltd(002727) board of directors
March 23, 2022
